IRM
50
3
WDC
50
3
ILMN
46
4
AMT
42
3
ROK
66
4
ADI
52
5
FTI
79
-2
PEP
50
2
DOW
46
2
IR
69
3
IBM
61
3
NEM
48
2
CSX
64
4
HOG
39
4
FE
52
2
CVS
57
7
ZBH
63
3
AVGO
27
5
EXR
64
4
AKAM
53
2
IRM
50
3
WDC
50
3
ILMN
46
4
AMT
42
3
ROK
66
4
ADI
52
5
FTI
79
-2
PEP
50
2
DOW
46
2
IR
69
3
IBM
61
3
NEM
48
2
CSX
64
4
HOG
39
4
FE
52
2
CVS
57
7
ZBH
63
3
AVGO
27
5
EXR
64
4
AKAM
53
2
Financhill
Back

Anebulo Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
21

ANEB
Anebulo Pharmaceuticals

Last Price:
1.51
Seasonality Move:
20.03%
Sell
20

NBY
NovaBay Pharmaceuticals

Last Price:
0.60
Seasonality Move:
1.46%
Sell
21
Anebulo Pharmaceuticals (ANEB) is a Sell

Is Anebulo Pharmaceuticals a Buy, Sell or Hold?

  • The current Anebulo Pharmaceuticals [ANEB] share price is $1.40. The Score for ANEB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • ANEB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.62. The Score for NBY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ANEB Stock Price Chart

What is Anebulo Pharmaceuticals's stock price today?

  • The Anebulo Pharmaceuticals share price today is $1.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANEB is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

ANEB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 34.17 Sell
Chaikin Money Flow: -11051 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.52 - 1.86) Sell
Bollinger Bands (100): (1.7 - 2.26) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 41.04 Sell
Chaikin Money Flow: -92985 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Sell
Bollinger Bands (100): (0.27 - 1.39) Sell

ANEB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.5 Sell
20-day SMA: 1.65 Sell
50-day SMA: 1.85 Sell
200-day SMA: 2.28 Sell
8-day EMA: 1.5 Sell
20-day EMA: 1.62 Sell
50-day EMA: 1.78 Sell
200-day EMA: 2.15 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.7 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.67 Sell
200-day SMA: 2.31 Sell
8-day EMA: 0.69 Sell
20-day EMA: 0.69 Sell
50-day EMA: 0.73 Sell
200-day EMA: 5.52 Sell

Anebulo Pharmaceuticals Earnings Growth & ANEB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.09 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Anebulo Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):